Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

TheraCryf PLC (TCF)

London
Currency in GBP
0.53
-0.01(-1.89%)
Closed
TCF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.510.53
52 wk Range
0.492.00
Key Statistics
Edit
Bid/Ask
0.50 / 0.55
Prev. Close
0.53
Open
0.51
Day's Range
0.51-0.53
52 wk Range
0.49-2
Volume
10.5K
Average Vol. (3m)
618.96K
1-Year Change
-68.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TCF Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

TheraCryf PLC Company Profile

Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders. The company’s lead product is SFX-01 that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase I clinical trials for the treatment of neurodevelopmental disorders and glioblastoma, as well as in preclinical stage for the treatment of rhabdomyosarcoma. In addition, it engages in the development of orexin 1 antagonist, which is in late preclinical stage targeting addiction and anxiety; and atypical dopamine transporter inhibitor (DAT), which is in late preclinical stage targeting fatigue and narcolepsy. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Compare TCF to Peers and Sector

Metrics to compare
TCF
Peers
Sector
Relationship
P/E Ratio
−0.8x−3.3x−0.7x
PEG Ratio
−0.02−0.030.00
Price / Book
0.9x3.3x2.6x
Price / LTM Sales
-14.3x3.2x
Upside (Analyst Target)
-95.8%45.9%
Fair Value Upside
Unlock2.1%7.6%Unlock

FAQ

What Is the TheraCryf (TCF) Stock Price Today?

The TheraCryf stock price today is 0.53

What Stock Exchange Does TheraCryf Trade On?

TheraCryf is listed and trades on the London stock exchange.

What Is the Stock Symbol for TheraCryf?

The stock symbol for TheraCryf is "TCF."

What Is the TheraCryf Market Cap?

As of today, TheraCryf market cap is 2.19M.

What is TheraCryf Earnings Per Share?

The TheraCryf EPS is -0.008.

From a Technical Analysis Perspective, Is TCF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.